Life sciences news
-
eTheRNA raises EUR 34 million in Series B financing to accelerate multiple mRNA therapeutic development programs through to clinical proof of concept
Wednesday June 17th 2020
Read more
-
Johnson & Johnson announces acceleration of its COVID-19 vaccine candidate
Thursday June 11th 2020
Read more
-
New analyses of Phase 2 Equator Clinical Program support durable efficacy of Filgotinib in Psoriatic Arthritis
Monday June 8th 2020
Read more
-
Filgotinib demonstrates durable efficacy and consistent safety profile at 52 weeks in Finch 1 and 3 studies in rheumatoid arthritis
Thursday June 4th 2020
Read more
-
Celyad provides update on allogeneic CAR-T franchise
Tuesday June 2nd 2020
Read more
-
argenx announces positive topline results from Phase 3 ADAPT Trial of Efgartigimod in patients with Generalized Myasthenia Gravis
Tuesday May 26th 2020
Read more
-
Gilead and Galapagos announce positive topline results of Phase 2B/3 trial of Filgotinib
Thursday May 21st 2020
Read more
-
Bone Therapeutics treats first patients in pivotal JTA-004 phase III knee osteoarthritis study
Monday May 18th 2020
Read more
-
Become a flanders.bio member
Your news here?
-
Progressing clinical development of next generation therapies for Diabetic eye disease – beyond anti-VEGF
Friday May 8th 2020
Read more
-
Galapagos: On track for clinical read-outs
Friday May 8th 2020
Read more
-
VIB’s efforts in COVID-19 testing
Thursday May 7th 2020
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
